Clincosm LogoSign in Get a demo

Evaluation of Cognitive Status, Kinesiophobia, Physical Activity Level, and Functional Performance in Coronary Intensive Care

Sponsor
Hacettepe University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05553106
Collaborator
(none)
10
Enrollment
1
Location
1.3
Anticipated Duration (Months)
7.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of our study is to evaluate cognitive status, kinesiophobia, physical activity level, and functional performance in coronary intensive care.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This study will be performed on patients who are hospitalized in the coronary intensive care unit, who can take simple commands, and whose condition is physiologically stable.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    10 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of Cognitive Status, Kinesiophobia, Physical Activity Level, and Functional Performance in Coronary Intensive Care
    Actual Study Start Date :
    Sep 23, 2022
    Anticipated Primary Completion Date :
    Nov 1, 2022
    Anticipated Study Completion Date :
    Nov 1, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    Study Group

    Patients who are hospitalized in the coronary intensive care unit, who can take simple commands, and whose condition is physiologically stable.

    Outcome Measures

    Primary Outcome Measures

    1. Functional Performance Assessment [2 weeks]

      Functional status score for the intensive care unit (FSS-ICU) will be used.

    Secondary Outcome Measures

    1. Symptom Assessment [2 weeks]

      Cardiac symptom survey will be used.

    2. Cognitive Status Assessment [2 weeks]

      The Montreal Cognitive Assessment (MoCA) will be used

    3. Physical Activity Level [2 weeks]

      Physical activity level will be evaluated using the International Physical Activity Questionnaire - Short Form (IPAQ-SF).

    4. Fear of Movement [2 weeks]

      Fear of movement will be evaluated using the Fear of Activity in Patients with Coronary Artery Disease (Fact-CAD).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Volunteering to participate in the research

    • Being under surveillance in the coronary intensive care unit

    Exclusion Criteria:

    • Presence of neurological disease that may affect the cognitive status

    • Not being clinically stable

    • Not to cooperate

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hacettepe University Ankara Turkey

    Sponsors and Collaborators

    • Hacettepe University

    Investigators

    • Study Director: Naciye Vardar-Yagli, PhD, Hacettepe University
    • Study Director: Hikmet Yorgun, PhD, Hacettepe University
    • Study Chair: Ahmet Hakan Ates, PhD, Hacettepe University
    • Principal Investigator: Dilara Saklica, MSc, Hacettepe University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dilara Saklica, Principal Investigator, Hacettepe University
    ClinicalTrials.gov Identifier:
    NCT05553106
    Other Study ID Numbers:
    • GO 20/299
    First Posted:
    Sep 23, 2022
    Last Update Posted:
    Oct 21, 2022
    Last Verified:
    Oct 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dilara Saklica, Principal Investigator, Hacettepe University
    intensive care
    coronary artery disease
    kinesiophobia
    physical activity level
    Additional relevant MeSH terms:
    Heart Diseases

    Study Results

    No Results Posted as of Oct 21, 2022